ACETAMINOPHEN (ACETAMINOPHEN) — FDA Approval ANDA214331 (BAXTER HLTHCARE CORP)
ACETAMINOPHEN (ACETAMINOPHEN) — FDA Approval ANDA214331 (BAXTER HLTHCARE CORP) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: ACETAMINOPHEN; Active ingredients: ACETAMINOPHEN; Application number: ANDA214331.
| Brand name | ACETAMINOPHEN |
|---|---|
| Active ingredients | ACETAMINOPHEN |
| Application number | ANDA214331 |
| Sponsor | BAXTER HLTHCARE CORP |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Marketing status | Prescription |
| Products in application | 2 |
| First approval date | 20210917 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →